Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-06-22

FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for brinzolamide by Sandoz Inc. to update the product labeling. The update may reflect changes to indications, dosing, s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brinzolamide (Brinzolamide)

Snippet

SUPPL AP for BRINZOLAMIDE (BRINZOLAMIDE)